| Issue Date | Title | Author(s) |
| 2022 | Endothelial dysfunction: developmental mechanisms and therapeutic strategies | Shcheblykin, D. V.; Bolgov, A. A.; Pokrovskii, M. V.; Stepenko, Yu. V.; Tsuverkalova, Y. M.; Shcheblykina, O. V.; Korokina, L. V. |
| 2022 | Experimental study of new derivatives of 3-hydroxypyridine as pharmacological agents for the correction of ischemic brain injury after intracerebral hemorrhage | Shcheblykina, O. V.; Shcheblykin, D. V.; Trunov, K. S.; Danilenko, A. P.; Lipatov, V. S. |
| 2021 | Genetically modified animals for use in bio‑pharmacology: from research to production | Deykin, A. V.; Shcheblykina, O. V.; Povetka, E. E.; Golubinskaya, P. A.; Pokrovsky, V. M. |
| 2018 | Morphology of the rat’s brain in four vessels model of ischemic stroke after administration of carbamylated darbepoetin | Tverskoy, A. V.; Kolesnichenko, P. D.; Shcheblykina, O. V.; Gorbunova, N. S.; Morozov, V. N. |
| 2019 | Neuroprotective effects of taurine and 3-hydroxypyridine derivatives in the intracerebral hemorrhage model in rats | Nesterova, N. I.; Shcheblykina, O. V.; Kolesnichenko, P. D.; Nesterov, A. V.; Shcheblykin, D. V. |
| 2018 | Pharmacological screening of substances with cardioprotective effect in the group of 3-oxypyridine derivatives | Danilenko, L. M.; Skachilova, S. Ya.; Nadezhdin, S. V.; Timokhina, A. S.; Shcheblykina, O. V. |
| 2023 | Pulmonary hypertension: modern methods of treatment and ways of their long-term development | Zagrebelnaya, A. V.; Korokina, L. V.; Malorodova, T. N.; Shcheblykina, O. V.; Avtina, T. V.; Bolgov, A. A. |
| 2024 | Study of the neuroprotective properties of the heteroreceptor EPOR/CD131 agonist of peptide structure in tau-proteinopathy modeling | Stepenko, Yu. V.; Shmigerova, V. S.; Kostina, D. A.; Shcheblykina, O. V.; Zhernakova, N. I.; Solin, A. V.; Koroleva, N. V.; Markovskaya, V. A.; Dudnikova, O. V.; Bolgov, A. A. |
